title: The M4 muscarinic receptor-selective effects on keratinocyte crawling locomotion.
abstract: We have investigated how the cholinergic system of epidermal keratinocytes (KC) controls migratory function of these cells. Several molecular subtypes of muscarinic acetylcholine receptors (mAChRs) have been detected in KC. Early results suggested that M(4) is the predominant mAChR regulating cell motility. To determine muscarinic effects on lateral migration of KC, we used an agarose gel keratinocyte outgrowth system (AGKOS) which provides for measurements of the response of large cell populations (> 10(4) cells). Muscarine produced a dose-dependent stimulatory effect on cell migration (p < 0.05). This activity was abolished by atropine, which decreased migration distance when given alone. To identify the mAChR subtype(s) mediating these muscarinic effects, we substituted atropine with subtype-selective antagonists. Tropicamide (M(4)-selective) was more effective at decreasing the migration distance than pirenzepine and 4-DAMP at nanomolar concentrations. We then compared lateral migration of KC obtained from M(4) mAChR knockout mice with that of wild-type murine KC, using AGKOS. In the absence of M(4) mAChR, the migration distance of KC was significantly (p < 0.05) decreased. These results indicate that the M(4) mAChR plays a central role in mediating cholinergic control of keratinocyte migration by endogenous acetylcholine produced by these cells.
authors.affiliation: Department of Dermatology, University of California, Davis, 4860 Y Street, #3400, Sacramento, CA 95817, USA.
authors.forename: Alex I
authors.initials: AI
authors.lastname: Chernyavsky
authors.forename: Vu Thuong
authors.initials: VT
authors.lastname: Nguyen
authors.forename: Juan
authors.initials: J
authors.lastname: Arredondo
authors.forename: Assane
authors.initials: A
authors.lastname: Ndoye
authors.forename: Shaheen
authors.initials: S
authors.lastname: Zia
authors.forename: Jürgen
authors.initials: J
authors.lastname: Wess
authors.forename: Sergei A
authors.initials: SA
authors.lastname: Grando
mesh_terms: D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002465:Cell Movement / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D007231:Infant, Newborn; D015603:Keratinocytes / Q000187:drug effects / Q000502:physiology*; D051379:Mice; D018345:Mice, Knockout; D009116:Muscarine / Q000494:pharmacology; D018721:Muscarinic Agonists / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D010890:Pirenzepine / Q000494:pharmacology; D043588:Receptor, Muscarinic M4; D011976:Receptors, Muscarinic / Q000502:physiology*; D013268:Stimulation, Chemical
chemical_list: D018721:Muscarinic Agonists; D010880:Piperidines; D043588:Receptor, Muscarinic M4; D011976:Receptors, Muscarinic; D010890:Pirenzepine; D001285:Atropine; D009116:Muscarine; C042375:4-diphenylacetoxy-1,1-dimethylpiperidinium